FDA Advisory Committee to Discuss Blood Safety and Availability

Summary

The U.S. Food and Drug Administration (FDA) has scheduled a meeting of its Advisory Committee on Blood Safety and Availability to discuss blood safety and availability, as mandated by the National Organ Transplant Act of 1984.